Comparative eco-toxicities of nano-ZnO particles under aquatic and aerosol exposure modes.
The antimicrobial activity of ZnO nanoparticles (NPs) was investigated under aquatic and aerosol exposure modes. ZnO NPs in aquatic media aggregated to micrometer-sized particles and did not interact with microorganisms effectively. Hence, the inhibition of microbial growth by nano-ZnO NPs (e.g., Mycobacterium smegmatis and Cyanothece 51142) in aquatic media was mainly attributable to dissolved zinc species. Shewanella oneidensis MR-1 and Escherichia coli were able to produce large amounts of extracellular polymeric substances, and their growth was not inhibited by ZnO NPs in aquatic media, even at high concentrations (>40 mg/L). On the other hand, when ZnO NPs were electrosprayed onto an E. coli biofilm so that NPs could be directly deposited onto the cell surface, the aerosol exposure dramatically reduced cellular viability. For example, an electrospray of ZnO NPs (20 nm) reduced the total number of viable E.coli cells by 57% compared to the control case, in which we electrosprayed only the buffer solution. However, electrospraying large-sized ZnO particles (480 nm) or nonsoluble TiO(2) NPs (20 nm) caused much less lethality to E. coli cells. The above observation implies that the aerosol method of exposing ZnO NPs to biological systems appears to have a much higher antimicrobial activity, and thus may lead to practical applications of employing a novel antimicrobial agent for airborne disease control.
Wu
Bing
B
Department of Energy, Environmental and Chemical Engineering, Washington University, St. Louis, Missouri 63130, USA.
Wang
Yin
Y
Lee
Yi-Hsuan
YH
Horst
Angela
A
Wang
Zhipeng
Z
Chen
Da-Ren
DR
Sureshkumar
Radhakrishna
R
Tang
Yinjie J
YJ
D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000633:toxicity*; D046889:Cyanothece / Q000187:drug effects; D004926:Escherichia coli / Q000187:drug effects; D008855:Microscopy, Electron, Scanning; D046529:Microscopy, Electron, Transmission; D020102:Mycobacterium smegmatis / Q000187:drug effects; D053758:Nanoparticles / Q000008:administration & dosage / Q000633:toxicity* / Q000648:ultrastructure; D020592:Shewanella / Q000187:drug effects; D015034:Zinc Oxide / Q000008:administration & dosage / Q000633:toxicity*
D000890:Anti-Infective Agents; D015034:Zinc Oxide